Another Blood Pressure Medication Gets Recalled Over Cancer Causing Concerns

January 03, 2019Jan 03, 2019

A major recall has people checking their medicine cabinets all over the nation. It is the third time a scary incident has happened to people who take blood pressure medication.

The FDA has just announced that Aurobindo Pharma USA Inc. is voluntarily recalling 80lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets. They have found that the medicine may potentially contain N-nitrosodiethylamine (NDEA), a substance thought to be a probably human carcinogen.

The recall comes juts weeks after another blood pressure medication was yanked from shelves. That recall involved Torrent Pharmaceuticals.

According to reports, "Torrent Pharmaceuticals Limited is recalling two lots of a blood pressure medication after finding trace amounts of a cancer-causing chemical.The FDA says the product Losartan contains trace amounts of a substance that occurs naturally in certain foods, drinking water, air pollution and industrial processes. It's been classified as a probable human carcinogen."

The recalled Losartan medications can be found below:

-LOSARTAN POTASSIUM TAB 100 mg, 30 ct bottles-lot/batch BO31C016

-LOSARTAN POTASSIUM TAB 100 mg, 90 ct bottles-lot/batch BO31C016

-LOSARTAN POTASSIUM TAB 100 mg, 1000 ct bottles-lot/batch 4DK3C005

If you currently take any of these medications, officials ask that you speak with your doctor immediately but continue to take the medicine. Stopping treatment can be harmful. Your doctor should be able to advise you about a good plan moving forward.

What do you think about this? Let us know! Be sure to leave your thoughts in the comments section of our Facebook page. We truly appreciate your readership! Be sure to stay caught up on the latest news with our trending articles. Today's trending article is: Trump Digs Up Dirt on Obama, Uses Barack's Own Quote to Destroy Immigration Critics